Allarity Therapeutics Inc

NASDAQ:ALLR   12:59:44 AM EDT
0.44
+0.01 (+2.80%)
Earnings Announcements

Allarity Therapeutics Reports Third Quarter 2022 Financial Results

Published: 11/15/2022 21:15 GMT
Allarity Therapeutics Inc (ALLR) - Allarity Therapeutics Reports Third Quarter 2022 Financial Results.
Allarity Therapeutics Inc - Qtrly Basic and Diluted Net Loss per Common Stock $0.68.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.